microICSI
Male infertility is responsible for half of infertility cases worldwide. microICSI reduces the amount of time required to perform ICSI, meaning that IVF clinics can treat more patients, faster.
Male infertility is responsible for half of infertility cases worldwide. Around the world, sperm counts are dropping significantly and the demand for ICSI, the only treatment available for male infertility cases, is increasing rapidly.
ICSI–intracytoplasmic sperm injection– is a time-consuming and complicated process that requires preparing and injecting an individual sperm into each egg. Embryologists must undergo extensive training to learn to work with several tools under a microscope to perform ICSI, and even then, mistakes still happen.
Our flagship device microICSI simplifies and streamlines the ICSI process, removing several steps and pieces of equipment from the procedure. The 3D printed device is smaller than a pinhead and holds multiple eggs in individual cradles in a platform called the nest. The cradles have channels that lead straight to each egg, enabling embryologists to quickly slide the injection pipette into the center of each egg for faster, more precise injection before moving onto the next cradle and egg.
microICSI enhances precision, improves embryo production, and accelerates injection speed. It increases pregnancy success rates by 15% and decreases procedure time by 50%.
Embryologists using microICSI require less training and their IVF labs require less equipment, which increases a lab’s capacity for offering ICSI while reducing the cost.
See how microICSI works